| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1527 |
| 1 | METHOTREXATE SODIUM | 1259 |
| 2 | LEFLUNOMIDE | 1169 |
| 3 | METHOTREXATE | 1160 |
| 4 | PREDNISONE | 1114 |
| 5 | RITUXIMAB | 1075 |
| 6 | ACETAMINOPHEN | 1051 |
| 7 | SECUKINUMAB | 1038 |
| 8 | DICLOFENAC SODIUM | 1028 |
| 9 | ETANERCEPT | 978 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NICOTINAMIDE | 226 | 0.0885 |
| 1 | AZATHIOPRINE SODIUM | 221 | 0.0871 |
| 2 | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | 238 | 0.0668 |
| 3 | GOLIMUMAB | 790 | 0.0627 |
| 4 | GOLD | 357 | 0.0615 |
| 5 | MINOCYCLINE HYDROCHLORIDE | 314 | 0.0530 |
| 6 | HYDROCORTISONE BUTYRATE | 96 | 0.0486 |
| 7 | BOTULINUM TOXIN TYPE A | 570 | 0.0446 |
| 8 | CORTISONE ACETATE | 556 | 0.0445 |
| 9 | 12%AZELAIC ACID | 35 | 0.0417 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2068 |
| 1 | Corticosteroid [EPC] | 1651 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1651 |
| 3 | Antirheumatic Agent [EPC] | 1169 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 1166 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1151 |
| 6 | Interleukin-17A Antagonist [EPC] | 1048 |
| 7 | Vitamin C [EPC] | 1037 |
| 8 | Provitamin D2 Compound [EPC] | 961 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 938 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 663 | 0.9637 |
| 1 | Provitamin D2 Compound [EPC] | 961 | 0.0323 |
| 2 | Oxaborole Antifungal [EPC] | 2 | 0.0286 |
| 3 | Interleukin-17A Antagonist [EPC] | 1048 | 0.0281 |
| 4 | Endoglycosidase [EPC] | 23 | 0.0124 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 24 | 0.0116 |
| 6 | beta3-Adrenergic Agonist [EPC] | 544 | 0.0114 |
| 7 | Antirheumatic Agent [EPC] | 1169 | 0.0110 |
| 8 | Aminosalicylate [EPC] | 910 | 0.0090 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 938 | 0.0068 |